Plasma ceramides are altered in MCI and predict cognitive decline and hippocampal volume loss

BACKGROUND: A blood-based biomarker of Alzheimer disease (AD) would be superior to CSF and neuroimaging measures in terms of cost, invasiveness and feasibility for repeated measures. We previously reported blood ceramides varied in relation to timing of memory impairment in a population-based study....

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Mielke, Michelle M., Haughey, Norman J., Bandaru, Veera Venkata Ratnam, Schech, Steven, Carrick, Richard, Carlson, Michelle C., Mori, Susumu, Miller, Michael I., Ceritoglu, Can, Brown, Timothy, Albert, Marilyn, Lyketsos, Constantine G.
Format: Artigo
Jezik:Inglês
Izdano: 2010
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC2933928/
https://ncbi.nlm.nih.gov/pubmed/20813340
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jalz.2010.03.014
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki